학술논문
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, January 2024, 13(2))
Subject
Language
English
ISSN
20457634